Clinical Research Directory
Browse clinical research sites, groups, and studies.
AI-TOP Study Artificial Intelligence for Trigger Optimization.
Sponsor: Fundacion Dexeus
Summary
To evaluate, in a randomized controlled trial, whether AI-guided monitoring and ovulation triggering leads to clinical outcomes comparable to those achieved through physician-led decision-making in patients undergoing ovarian stimulation for IVF.
Official title: An Artificial Intelligence Based Approach for Selecting the Optimal Day for Triggering.
Key Details
Gender
FEMALE
Age Range
18 Years - 42 Years
Study Type
INTERVENTIONAL
Enrollment
644
Start Date
2026-04
Completion Date
2027-09
Last Updated
2026-04-07
Healthy Volunteers
No
Interventions
STIMAI®.
The AI algorithm used in this study is STIMAI®. STIMAI® is an artificial intelligence-based software that assists clinicians by providing data-driven insights to optimize the fertility treatment process and support conception. The software is designed as a clinical decision support tool and does not replace the physician's judgment; final clinical decisions will remain under the responsibility of the treating physician The physician will consult the AI application, which predicts the number of MII oocytes for different trigger days. If the algorithm recommends triggering today or tomorrow, the physician will choose which option to follow.
Routine clinical management
As soon as 2-3 follicles of 17 mm are detected, the physician will determine the timing of ovulation triggering based on clinical judgment.
Locations (5)
Dexeus Mujer Sabadell
Sabadell, Barcelona, Spain
Dexeus Mujer Sant Cugat
Sant Cugat del Vallès, Barcelona, Spain
Dexeus Mujer Reus
Reus, Tarragona, Spain
Hospital Universitario Quiron Dexeus
Barcelona, Spain
Dexeus Mujer Tarragona
Tarragona, Spain